Neuravi introduces collaborative clot research initiative at ESMINT


Neuravi introduced the Neuravi Thromboembolic Initiative (NTI) during a series of workshops on “The Science of Clot” at the European Society of Minimally Invasive Neurological Therapy (ESMINT) conference in Nice, France. The NTI brings together Neuravi engineers with clinicians and researchers from leading international institutions in an effort to deepen the understanding of the mechanical properties of clot and occlusion dynamics, with the goal of improving the physician’s ability to restore flow in acute ischaemic stroke.

The ESMINT conference gathers leaders in minimally invasive neurological therapy from across Europe. “One of the goals of ESMINT is to advance the practice of neuro-intervention through the support of research, education and training,” observed Laurent Pierot, president of the ESMINT Congress. “Currently, there is a growing interest in identifying different clots and in understanding how different clot characteristics may impact treatment in acute ischaemic stroke. The NTI workshops will help in these efforts.”


The NTI workshops featured a presentation by Anastasios Mpotsaris, Uniklinik Köln, as well as interactive hands-on sessions with engineers exploring clot characterisation, the dynamics of occlusion formation and clot-device interactions and any potential implications for revascularisation.


“The NTI represents Neuravi’s commitment to advance the treatment of stroke by investing and collaborating in research to unravel the science of stroke occlusion,” states Eamon Brady, chief executive officer of Neuravi. “We are excited to have this opportunity to both share and learn with the neurointerventional community during these interactive workshops.”